| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 134, 1121-1126, Copyright © 1994 by Endocrine Society
ARTICLES |
T Shuto, T Kukita, M Hirata, E Jimi and T Koga
Department of Biochemistry, Faculty of Dentistry, Kyushu University, Fukuoka, Japan.
We investigated the effect of glucocorticoid on the generation of osteoclasts. In mouse bone marrow culture systems, dexamethasone, a synthetic glucocorticoid analog, enhanced osteoclast-like cell formation induced by 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] in a dose- dependent manner. Conversely, dexamethasone inhibited the endogenous production of granulocyte-macrophage colony-stimulating factor (GM-CSF) in bone marrow cultures. GM-CSF, when added exogenously, suppressed not only the osteoclast-like cell formation induced by 1,25-(OH)2D3, but also the stimulatory effect of dexamethasone, and addition of anti-GM- CSF neutralizing antibody to the cultures significantly increased the osteoclast-like cell formation induced by 1,25-(OH)2D3. These observations suggest that dexamethasone directly affects bone marrow cells and enhances osteoclast generation by inhibiting the endogenous production of GM-CSF, which may function as a negative regulator of osteoclast formation.
This article has been cited by other articles:
![]() |
C. Swanson, M. Lorentzon, H. H. Conaway, and U. H. Lerner Glucocorticoid Regulation of Osteoclast Differentiation and Expression of Receptor Activator of Nuclear Factor-{kappa}B (NF-{kappa}B) Ligand, Osteoprotegerin, and Receptor Activator of NF-{kappa}B in Mouse Calvarial Bones Endocrinology, July 1, 2006; 147(7): 3613 - 3622. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Take, Y. Kobayashi, Y. Yamamoto, H. Tsuboi, T. Ochi, S. Uematsu, N. Okafuji, S. Kurihara, N. Udagawa, and N. Takahashi Prostaglandin E2 Strongly Inhibits Human Osteoclast Formation Endocrinology, December 1, 2005; 146(12): 5204 - 5214. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Oursler, E. W. Bradley, S. L. Elfering, and C. Giulivi Native, not nitrated, cytochrome c and mitochondria-derived hydrogen peroxide drive osteoclast apoptosis Am J Physiol Cell Physiol, January 1, 2005; 288(1): C156 - C168. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Takuma, T. Kaneda, T. Sato, S. Ninomiya, M. Kumegawa, and Y. Hakeda Dexamethasone Enhances Osteoclast Formation Synergistically with Transforming Growth Factor-{beta} by Stimulating the Priming of Osteoclast Progenitors for Differentiation into Osteoclasts J. Biol. Chem., November 7, 2003; 278(45): 44667 - 44674. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-K. Lee, J. F. Kalinowski, S. L. Jastrzebski, L. Puddington, and J. A. Lorenzo Interleukin-7 Is a Direct Inhibitor of in Vitro Osteoclastogenesis Endocrinology, August 1, 2003; 144(8): 3524 - 3531. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-K. Lee, J. Kalinowski, S. Jastrzebski, and J. A. Lorenzo 1,25 (OH)2 Vitamin D3-Stimulated Osteoclast Formation in Spleen-Osteoblast Cocultures Is Mediated in Part by Enhanced IL-1{alpha} and Receptor Activator of NF-{kappa}B Ligand Production in Osteoblasts J. Immunol., September 1, 2002; 169(5): 2374 - 2380. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lethimonier, G. Flouriot, O. Kah, and B. Ducouret The Glucocorticoid Receptor Represses the Positive Autoregulation of the Trout Estrogen Receptor Gene by Preventing the Enhancer Effect of a C/EBP{beta}-Like Protein Endocrinology, August 1, 2002; 143(8): 2961 - 2974. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Lean, K. Fuller, and T. J. Chambers FLT3 ligand can substitute for macrophage colony-stimulating factor in support of osteoclast differentiation and function Blood, November 1, 2001; 98(9): 2707 - 2713. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Bost, J. L. Bento, J. K. Ellington, I. Marriott, and M. C. Hudson Induction of Colony-Stimulating Factor Expression following Staphylococcus or Salmonella Interaction with Mouse or Human Osteoblasts Infect. Immun., September 1, 2000; 68(9): 5075 - 5083. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Huang, J. Xu, D. J. Wood, and M. H. Zheng Gene Expression of Osteoprotegerin Ligand, Osteoprotegerin, and Receptor Activator of NF-{kappa}B in Giant Cell Tumor of Bone : Possible Involvement in Tumor Cell-Induced Osteoclast-Like Cell Formation Am. J. Pathol., March 1, 2000; 156(3): 761 - 767. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. O. Abu, A. Horner, V. Kusec, J. T. Triffitt, and J. E. Compston The Localization of the Functional Glucocorticoid Receptor {alpha} in Human Bone J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 883 - 889. [Abstract] [Full Text] |
||||
![]() |
I. R. Reid Glucocorticoid Osteoporosis: Reid IR Glucocorticoid osteoporosis J Intensive Care Med 1999, 14231-242 J Intensive Care Med, September 1, 1999; 14(5): 231 - 242. [PDF] |
||||
![]() |
S.-K. Lee and J. A. Lorenzo Parathyroid Hormone Stimulates TRANCE and Inhibits Osteoprotegerin Messenger Ribonucleic Acid Expression in Murine Bone Marrow Cultures: Correlation with Osteoclast-Like Cell Formation Endocrinology, August 1, 1999; 140(8): 3552 - 3561. [Abstract] [Full Text] |
||||
![]() |
C. A. Roca, P. J. Schmidt, and D. R. Rubinow Review : Gonadal Steroids and Affective Illness Neuroscientist, July 1, 1999; 5(4): 227 - 237. [Abstract] [PDF] |
||||
![]() |
K. Matsuzaki, K. Katayama, Y. Takahashi, I. Nakamura, N. Udagawa, T. Tsurukai, R. Nishinakamura, Y. Toyama, Y. Yabe, M. Hori, et al. Human Osteoclast-Like Cells Are Formed from Peripheral Blood Mononuclear Cells in a Coculture with SaOS-2 Cells Transfected with the Parathyroid Hormone (PTH)/PTH-Related Protein Receptor Gene Endocrinology, February 1, 1999; 140(2): 925 - 932. [Abstract] [Full Text] |
||||
![]() |
Y. Y. Myint, K. Miyakawa, M. Naito, L. D Shultz, Y. Oike, K.-i. Yamamura, and K. Takahashi Granulocyte/Macrophage Colony-Stimulating Factor and Interleukin-3 Correct Osteopetrosis in Mice with Osteopetrosis Mutation Am. J. Pathol., February 1, 1999; 154(2): 553 - 566. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. R. Reid Glucocorticoid Effects on Bone J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 1860 - 1862. [Full Text] |
||||
![]() |
R. M. Uht, C. M. Anderson, P. Webb, and P. J. Kushner Transcriptional Activities of Estrogen and Glucocorticoid Receptors Are Functionally Integrated at the AP-1 Response Element Endocrinology, July 1, 1997; 138(7): 2900 - 2908. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Udagawa, N. J. Horwood, J. Elliott, A. Mackay, J. Owens, H. Okamura, M. Kurimoto, T. J. Chambers, T. J. Martin, and M. T. Gillespie Interleukin-18 (Interferon-gamma -inducing Factor) Is Produced by Osteoblasts and Acts Via Granulocyte/Macrophage Colony-stimulating Factor and Not Via Interferon-gamma to Inhibit Osteoclast Formation J. Exp. Med., March 17, 1997; 185(6): 1005 - 1012. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |